The Development of Forced Degradation and Stability Indicating Studies of Drugs- A Review
Force degradation study is an essential study that provides the knowledge & judgement to develop a stability indicating analytical method. This study helps to establish the specification and shelf life of a drug substance or drug product. Force degradation study show the chemical behaviour of the molecule which in turn helps in the development of formulation and package. This helps to describe the analytical methods helpful for development of stability indicating method. In addition, the regulatory guidance is very general and does not explain about the performance of forced degradation studies. Thus, this review discusses the current trends in performance of forced degradation studies by providing a strategy for conducting studies on degradation mechanisms and also describes the analytical methods helpful for development of stability indicating method.
2. Kanthale SB, Thonte SS, Supekar BB. Development of stability indicating assay method: a review. International Journal of Pharmaceutical Sciences and Research. 2019; 10(4):1625-31.
3. Patel RM, Patel PM, Patel NM.Stability Indicating HPLC Method Development-A Review. International Reasearch Journal of Pharmacy. 2011; 2(5):79-87.
4. Patel NN, Kothari CS. Critical review: Significance of Force degradation study with respect to current Pharmaceutical Scenario. Asian J. Research Chem. 2013; 6(3):286-96.
5. Maggio RM, Vignaduzzo SE, Kaufman TS. Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulations. TrAC- Trends in Analytical Chemistry. 2013; 49:57–70.
6. Patel D,Patel M, Ahir K, Singh S. A Review Article on Development of Forced Degradation and Stability Indicating Studies for Drug Substance and Drug Product. J Pharm SciBioscientificResearch.2019; 9(2),165–72.
7. Sutar SV, Yeligar VC, Patil SS. A Review: Stability Indicating Forced Degradation Studies. Research J. Pharm. and Tech. 2019; 12(2):885-90.
8. Husain A. Forced Degradation Studies. JAPLR [Internet]. 2016 Dec 14 [cited 2021 Nov 29]; 3(6).
9. Joshi AS, Nadre AK. Forced Degradation Study: An Overview. International Journal of Research and analytical reviews IJRAR.2018; 5(3):479-82.
10. Thakor KA, Bhavsar DD, Thakor JR. A review article – development of forced degradation and stability indicating studies for drug substance and drug product. International Journal of Research in Pharmacology and Pharmacotherapeutics. 2016;5(4):291-97.
11. Janzen H. Forced degradation studies – comparison between ICH, EMA, FDA and WHO guidelines and ANVISA’s resolution RDC 53/2015. DGRA- German Society For Regulatory Affairs. 2016:1-51
12. Deokate UA, Gorde AM. Forced degradation and Stability Testing: Strategies and Analytical Perspectives. PharmaTutor.2014;2(6):61-74.
13. Quadri SS, Sonwane LV, Poul BN, Kamshette SN. Review on Stability Indicating Assay Methods (SIAMs). PharmaTutor.2014; 2(8):16-31.
14. Ngwa G. Forced Degradation as an Integral Part of HPLC Stability-Indicating Method Development. Drug delivery technology.2010 June;10(5):4.
15. Patolia VN. An Introduction To Forced Degradation Studies For Drug Substance & Drug Product. Pharmaceutical online[Internet]. 2020 January 9 [cited 2021 Nov 29]. Available from:
16. Rao BV, Sowjanya GN, Ajitha A, Rao VUM. A Review On Stability Indicating Hplc Method Development. World Journal of Pharmacy and Pharmaceutical Sciences. 2015;4(08):405-23.
17. Bhaskar R, Ola M, Agnihotri V, Chavan A, Girase H. Current Trend in Performance of Forced Degradation Studies for Drug Substance and Drug Product’s. Journal of Drug Delivery and Therapeutics. 2020 Apr 15;10(2-s):149–55.
18. Deokate U, Gorde AM. Forced Degradation and Stability Testing: Strategies and Analytical Perspectives. International Journal of Pharmaceutical Sciences Review and Research. 2014;26(2):242-50.
19. Sreelekha CR, Sahoo NK. A Review on Stability Indicating Method Development and Validation using HPLC and PDA. American Journal of Phytomedicine and clinical Therapeutics. 2021;9(8:39):1-4.
20. Rawat T, Pandey IP. Forced degradation studies for Drug Substances and Drug Products- Scientific and Regulatory Considerations. Journal of Pharmaceutical Science and Research. 2015;7(5):238-41.
21. Shah BP, Jain S, Prajapati KK, Mansuri NY. Stability Indicating HPLC Method Development: A Review. International Journal of Pharmaceutical Sciences and Research. 2012;3(9):2978-88.
22. Vyas AJ, Visana NM, Patel AI, Patel AB, Patel NK, Shah SR.Analytical Quality by Design in Stress Testing or Stability - Indicating Method. Asian Journal of Pharmaceutical Analysis. 2021;11(2):170-8. doi: 10.52711/2231-5675.2021.00029
23. Sahoo NK, Rajitha R, Sai Muralikrishna K. A Newer RP – HPLC Stability Indicating Method Development and Validation of Darunavir in its Bulk and Formulation. Austin J Anal Pharm Chem. 2019;6(3):1123.
24. Ravisankar P, Swathi V, Babu PS, Sulthana S, Gousepeer SK. Current Trends in Performance of Forced Degradation Studies and Stability Indicating Studies of Drugs. IOSR Journal of Pharmacy and Biological Sciences.2017;12(6):17-36.
25. Patel NN, Kothari CS. Critical review: Significance of Force degradation study with respect to current Pharmaceutical Scenario. Asian Journal of Research in Chemistry. 2013 March;6(3):286-96.
26. Roge AB,Tarte PS, Kumare MM, Shendarkar GR, Vadvalkar SM. Forced Degradation Study: An Important Tool in Drug Development. Asian Journal of Pharmaceutical Research. 2013;3(4):198-201.
27. Ambhore JP, Adhao VS, Cheke RS, Popat RR, Gandhi SJ. Futuristic review on progress in force degradation studies and stability indicating assay method for some antiviral drugs. GSC Biological and Pharmaceutical Sciences. 2021 Jul 30;16(01):133–49.
28. Dr Raghunandan HV. Stability indicating methods indispensable in drug discovery.Pharmabiz[Internet]. 2014 Oct 2[cited 2021 Nov 9].
29. CioneAP, Tonhi E, Silva P. Stability Indicating Methods. In: Shoyama Y, editor. Quality Control of Herbal Medicines and Related Areas [Internet]. InTech; 2011 [cited 2021 Nov 30]. Available from:
Shinde NG, Bangar BN, Deshmukh SM, Sulake SP, Sherekar DP. Pharmaceutical forced degradation studies with regulatory consideration. Asian J Res Pharm Sci. 2013;3(4):178-88.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).